B.coagulans in the treatment of gastrointestinal diseases of inflammatory and functional nature: effectiveness from the standpoint of evidence-based medicine

Authors

DOI:

https://doi.org/10.22141/2308-2097.52.4.2018.154143

Keywords:

review, B.coagulans, Laktovit Forte, gastrointestinal diseases of inflammatory and functional nature

Abstract

The analysis of PubMed, Scopus, Web of Science, MedLine, The Cochrane Library, CyberLeninka, RISC databases was performed in the context of searching for information on the effectiveness of B.coagulans in the treatment of gastrointestinal diseases of inflammatory and functional nature. The system analysis of the information presented in this article fully complies with international recommendations on systematic methods of literature search and contains information on the role, significance, advantages, safety and effectiveness of this strain (GRAS Notice No. GRN 000660) and the options of using probiotics and B.coagulans preparations in humans, with evidence of the possibility of expanding indications for the administration of the probiotic B.coagulans (Laktovit Forte), in particular in irritable bowel syndrome.

Downloads

Download data is not yet available.

References

Abdhul K, Ganesh M, Shanmughapriya S, et al. Bacteriocinogenic potential of a probiotic strain Bacillus coagulans [BDU3] from Ngari. Int J Biol Macromol. 2015 Aug;79:800-6. doi: 10.1016/j.ijbiomac.2015.06.005.

Abhari K, Shekarforoush SS, Hosseinzadeh S, Nazifi S, Sajedianfard J, Eskandari MH. The effects of orally administered Bacillus coagulans and inulin on prevention and progression of rheumatoid arthritis in rats. Food Nutr Res. 2016 Jul 15;60:30876. doi: 10.3402/fnr.v60.30876.

Adami A, Cavazzoni V. Occurrence of selected bacterial groups in the faeces of piglets fed with Bacillus coagulans as probiotic. J Basic Microbiol. 1999;39(1):3-9.

Adewumi GA, Oguntoyinbo FA, Romi W, Singh T. A, Jeyaram K. Genome subtyping of autochthonous Bacillus species isolated from Iru, a fermented Parkia biglobosa seed. Food Biotechnol. 2014;28(3):250-268. doi: 10.1080/08905436.2014.931866.

Ash C, Farrow JAE, Wallbanks S, Collins MD. Phylogenetic heterogeneity of the genus Bacillus revealed by comparative analysis of small-subunit-ribosomal RNA sequences. Lett Appl Microbiol. 1991;13(4):202-206. doi: 10.1111/j.1472-765X.1991.tb00608.x.

Tidjiani Alou M, Rathored J, Khelaifia S, et al. Bacillus rubiinfantis sp. nov. strain mt2T, a new bacterial species isolated from human gut. New Microbes New Infect. 2015 Sep 16;8:51-60. doi: 10.1016/j.nmni.2015.09.008.

Alkaya B, Laleman I, Keceli S, Ozcelik O, Cenk Haytac M, Teughels W. Clinical effects of probiotics containing Bacillus species on gingivitis: a pilot randomized controlled trial. J Periodontal Res. 2017 Jun;52(3):497-504. doi: 10.1111/jre.12415. 

Tidjiani Alou M, Rathored J, Khelaifia S, et al. Bacillus rubiinfantis sp. nov. strain mt2T, a new bacterial species isolated from human gut. New Microbes New Infect. 2015 Sep 16;8:51-60. doi: 10.1016/j.nmni.2015.09.008. 

Altmeyer S, Kröger S, Vahjen W, Zentek J, Scharek-Tedin L. Impact of a probiotic Bacillus cereus strain on the jejunal epithelial barrier and on the NKG2D expressing immune cells during the weaning phase of piglets. Vet Immunol Immunopathol. 2014 Sep 15;161(1-2):57-65. doi: 10.1016/j.vetimm.2014.07.001. 

Angmo K, Kumari A, Savitri, Bhalla TC. Probiotic characterization of lactic acid bacteria isolated from fermented foods and beverage of Ladakh. LWT Food Sci Technol. 2016;66:428-435. doi: 10.1016/j.lwt.2015.10.057. 

Aminlari L, Shekarforoush SS, Hosseinzadeh S, Nazifi S, Sajedianfard J, Eskandari MH. Effect of Probiotics Bacillus coagulans and Lactobacillus plantarum on Lipid Profile and Feces Bacteria of Rats Fed Cholesterol-Enriched Diet. Probiotics Antimicrob Proteins. 2018 Oct 27. doi: 10.1007/s12602-018-9480-1.

Ash C, Farrow JAE, Wallbanks S, Collins MD. Phylogenetic heterogeneity of the genus Bacillus revealed by comparative analysis of small-subunit-ribosomal RNA sequences. Lett Appl Microbiol. 1991;13(4):202-206. doi: 10.1111/j.1472-765X.1991.tb00608.x. 

Bader J, Albin A, Stahl U. Spore-forming bacteria and their utilisation as probiotics. Benef Microbes. 2012 Mar 1;3(1):67-75. doi: 10.3920/BM2011.0039. 

Beaumont M. Flavouring composition prepared by fermentation with Bacillus spp. Int J Food Microbiol. 2002 May 25;75(3):189-96.doi: 10.1016/S0168-1605(01)00706-1.

Bergey DH, autor. Holt JG, editor. Bergey’s Manual of Determinative Bacteriology. 9th ed. Baltimore, MD: The Williams and Wilkens Company; 1994. 787 p.

Berthold-Pluta A, Pluta A, Garbowska M. The effect of selected factors on the survival of Bacillus cereus in the human gastrointestinal tract. Microb Pathog. 2015 May;82:7-14. doi: 10.1016/j.micpath.2015.03.015. 

Böhm ME, Huptas C, Krey VM, Scherer S. Massive horizontal gene transfer, strictly vertical inheritance and ancient duplications differentially shape the evolution of Bacillus cereusenterotoxin operons hbl, cytK and nhe. BMC Evol Biol. 2015 Nov 10;15:246. doi: 10.1186/s12862-015-0529-4. 

Butel MJ. Probiotics, gut microbiota and health. Med Mal Infect. 2014 Jan;44(1):1-8. doi: 10.1016/j.medmal.2013.10.002. 

Cai D, Liu M, Wei X, et al. Use of Bacillus amyloliquefaciens HZ-12 for high-level production of the blood glucose lowering compound, 1-deoxynojirimycin (DNJ), and nutraceutical enriched soybeans via fermentation. Appl Biochem Biotechnol. 2017 Mar;181(3):1108-1122. doi: 10.1007/s12010-016-2272-8. 

Casula G, Cutting SM. Bacillus probiotics: spore germination in the gastrointestinal tract. Appl Environ Microbiol. 2002 May;68(5):2344-52. doi: 10.1128/AEM.68.5.2344-2352.2002. 

Chantawannakul P, Oncharoen A, Klanbut K, Chukeatirote E, Lumyong S. Characterization of proteases of Bacillus subtilis strain 38 isolated from traditionally fermented soybean in northern Thailand. Sci Asia. 2002 Sep;28(3):241-245. doi: 10.2306/scienceasia1513-1874.2002.28.241.

Ghelardi E, Celandroni F, Salvetti S, Gueye SA, Lupetti A, Senesi S. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. J Appl Microbiol. 2015 Aug;119(2):552-9. doi: 10.1111/jam.12848.

Choi JH, Pichiah P, BT, Kim MJ, Cha YS. Cheonggukjang, a soybean paste fermented with B. licheniformis 67 prevents weight gain and improves glycemic control in high fat diet induced obese mice. J Clin Biochem Nutr. 2016 Jul;59(1):31-8. doi: 10.3164/jcbn.15-30.

Cutting SM. Bacillus probiotics. Food Microbiol. 2011 Apr;28(2):214-20. doi: 10.1016/j.fm.2010.03.007.

De Vecchi E, Drago L. Lactobacillus sporogenes or Bacillus coagulans: misidentification or mislabelling? International Journal of Probiotics and Prebiotics. 2006;1(1):3-10.

Keller D, Farmer S, McCartney A, Gibson G. Bacillus coagulans as a probiotic. Food Sci Technol Bull: Funct Foods. 2010;7:103-109. doi: 10.1616/1476-2137.16015.

Di Caro S, Tao H, Grillo A, et al. Bacillus clausiieffect on gene expression pattern in small bowel mucosa using DNA microarray analysis. Eur J Gastroenterol Hepatol. 2005 Sep;17(9):951-60. doi: 10.1097/00042737-200509000-00011. 

Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis. 2015 May 15;60 Suppl 2:S129-34. doi: 10.1093/cid/civ085. 

Drago L, Rodighiero V, Celeste T, Rovetto L, De Vecchi E. Microbiological evaluation of commercial probiotic products available in the United States in 2009. J Chemother. 2010 Dec;22(6):373-7. doi: 10.1179/joc.2010.22.6.373. 

Duc le H, Hong HA, Barbosa TM, Henriques AO, Cutting SM. Characterization of Bacillus probiotics available for human use. Appl Environ Microbiol. 2004 Apr;70(4):2161-71. doi: 10.1128/AEM.70.4.2161-2171.2004. 

Dudonné S, Varin TV, Anhê FF, et al. Modulatory effects of a cranberry extract co-supplementation with Bacillus subtilis CU1 probiotic on phenolic compounds bioavailability and gut microbiota composition in high-fat diet-fed mice. Pharma Nutr. 2015;3(3):89-100. doi: 10.1016/j.phanu.2015.04.002. 

Earl AM, Eppinger M, Fricke WF, et al. Whole-genome sequences of Bacillus subtilis and close relatives. J Bacteriol. 2012 May;194(9):2378-9. doi: 10.1128/JB.05675-11. 

Elshaghabee FMF, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives. Front Microbiol. 2017 Aug 10;8:1490. doi: 10.3389/fmicb.2017.01490.

Endres JR, Clewell A, Jade KA, Farber T, Hauswirth J, Schauss AG. Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol. 2009 Jun;47(6):1231-8. doi: 10.1016/j.fct.2009.02.018.

Fakhry S, Sorrentini I, Ricca E, De Felice M, Baccigalupi L.Characterization of spore forming Bacilli isolated from the human gastrointestinal tract. J Appl Microbiol. 2008 Dec;105(6):2178-86. doi: 10.1111/j.1365-2672.2008.03934.x. 

Fan B, Blom J, Klenk HP, Borriss R. Bacillus amyloliquefaciens, Bacillus velezensis and Bacillus siamensis form an operational group B. amyloliquefaciens within the B. subtilis species complex. Front Microbiol. 2017 Jan 20;8:22. doi: 10.3389/fmicb.2017.00022.

FAO; WHO. Health and Nutritional Properties of Probiotics in Food Including Powder Milk With Live Lactic Acid Bacteria: Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba, Argentina 1-4 October 2001. Rome: FAO/WHO; 2006. 56 p.

FAO; WHO. Guidelines for the Evaluation of Probiotics in Food: Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. Rome: Food and Agriculture Organization. FAO/WHO; 2002. 11 p.

Elshaghabee FMF, Rokana N, Gulhane RD, Sharma C, Panwar H. Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives. Front Microbiol. 2017 Aug 10;8:1490. doi: 10.3389/fmicb.2017.01490.

Fujiya M, Musch MW, Nakagawa Y, et al. The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe. 2007 Jun 14;1(4):299-308. doi: 10.1016/j.chom.2007.05.004. 

Ghani M, Ansari A, Aman A, Zohra RR, Siddiqui NN, Qader SA. Isolation and characterization of different strains of Bacillus licheniformis for the production of commercially significant enzymes. Pak J Pharm Sci. 2013 Jul;26(4):691-7.

Ghandi AB. Lactobacillus sporogenes, an advancement in Lactobacillus therapy. East Pharm. 1988:41-43.

Ghelardi E, Celandroni F, Salvetti S, Gueye SA, Lupetti A, Senesi S. Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation. J Appl Microbiol. 2015 Aug;119(2):552-9. doi: 10.1111/jam.12848.

Ghoneim MAM, Hassan AI, Mahmoud MG, Asker MS. Effect of polysaccharide from Bacillus subtilis sp. on cardiovascular diseases and atherogenic indices in diabetic rats. BMC Complement Altern Med. 2016 Mar 31;16:112. doi: 10.1186/s12906-016-1093-1.

Gobi N, Malaikozhundan B, Sekar V, et al. GFP tagged Vibrio parahaemolyticus Dahv2 infection and the protective effects of the probiotic Bacillus licheniformis Dahb1 on the growth, immune and antioxidant responses in Pangasius hypophthalmus. Fish Shellfish Immunol. 2016 May;52:230-8. doi: 10.1016/j.fsi.2016.03.006. 

Green DH, Wakeley PR, Page A, et al. Characterization of two bacillus probiotics. Appl Environ Microbiol. 1999 Sep;65(9):4288-91. 

Guo Z, Liu XM, Zhang QX, et al. Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2011 Nov;21(11):844-50. doi: 10.1016/j.numecd.2011.04.008.

Honda H, Hoyles L, Gibson GR, Farmer S, Keller D, McCartney AL. Impact of GanedenBC30 (Bacillus coagulans GBI-30, 6086) on population dynamics of the human gut microbiota in a continuous culture fermentation system. International Journal of Probiotics and Prebiotics. 2011;6(1):65-72.

Abdhul K, Ganesh M, Shanmughapriya S, et al. Bacteriocinogenic potential of a probiotic strain Bacillus coagulans [BDU3] from Ngari. Int J Biol Macromol. 2015 Aug;79:800-6. doi: 10.1016/j.ijbiomac.2015.06.005.

Hoffmann T, Troup B, Szabo A, Hungerer C, Jahn D. The anaerobic life of Bacillus subtilis: cloning of the genes encoding the respiratory nitrate reductase system. FEMS Microbiol Lett. 1995 Sep 1;131(2):219-25. doi: 10.1111/j.1574-6968.1995.tb07780.x. 

Hong HA, Duc le H, Cutting SM. The use of bacterial spore formers as probiotics. FEMS Microbiol Rev. 2005 Sep;29(4):813-35. doi: 10.1016/j.femsre.2004.12.001. 

Hong HA, Huang JM, Khaneja R, Hiep LV, Urdaci MC, Cutting SM. The safety of Bacillus subtilis and Bacillus indicus as food probiotics. J Appl Microbiol. 2008 Aug;105(2):510-20. doi: 10.1111/j.1365-2672.2008.03773.x.

Hong HA, Khaneja R, Tam NMK, et al. Bacillus subtilis isolated from the human gastrointestinal tract. Res Microbiol. 2009 Mar;160(2):134-43. doi: 10.1016/j.resmic.2008.11.002. 

Horosheva TV, Vodyanoy V, Sorokulova I. Efficacy of Bacillus probiotics in prevention of antibiotic-associated diarrhoea: a randomized, double-blind, placebo-controlled clinical trial. JMM Case Rep. 2014;1:1-6. doi: 10.1099/jmmcr.0.004036. 

Hosoi T, Kiuchi K. Chapter 9: Natto – a food made by fermenting cooked soybeans with Bacillus subtilis (natto). In: Farnworth ER, editor. Handbook of Fermented Functional Foods. Boca Raton, FL: CRC Press; 2003. 227-245 pp.

Hoyles L, Honda H, Logan NA, Halket G, La Ragione RM, McCartney AL. Recognition of greater diversity of Bacillus species and related bacteria in human faeces. Res Microbiol. 2012 Jan;163(1):3-13. doi: 10.1016/j.resmic.2011.10.004.

Hyronimus B, Le Marrec C, Sassi AH, Deschamps A. Acid and bile tolerance of spore-forming lactic acid bacteria. Int J Food Microbiol. 2000 Nov 1;61(2-3):193-7. doi: 10.1016/S0168-1605(00)00366-4.

Hyronimus B, Le Marrec C, Urdaci MC. Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. J Appl Microbiol. 1998 Jul;85(1):42-50.

Jager R, Shields KA, Lowery RP, et al. (2016). Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery. PeerJ. 2016 Jul 21;4:e2276. doi: 10.7717/peerj.2276.

Jeong H, Park SH, Choi SK. Draft genome sequences of four plant probiotic Bacillusstrains. Genome Announc. 2016 May 12;4(3). pii: e00358-16. doi: 10.1128/genomeA.00358-16.

Jensen GS, Cash HA, Farmer S, Keller D. Inactivated probiotic Bacillus coagulansGBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro. J Inflamm Res. 2017 Aug 7;10:107-117. doi: 10.2147/JIR.S141660.

Joseph B, Dhas B, Hena V, Raj J. Bacteriocin from Bacillus subtilis as a novel drug against diabetic foot ulcer bacterial pathogens. Asian Pac J Trop Biomed. 2013 Dec;3(12):942-6. doi: 10.1016/S2221-1691(13)60183-5. 

Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial Lancet. 2001 Apr 7;357(9262):1076-9. doi: 10.1016/S0140-6736(00)04259-8.

Karu R, Sumeri I. Survival of Lactobacillus rhamnosus GG during simulated gastrointestinal conditions depending on food matrix. J Food Res. 2016;5(5):57-66. doi: 10.5539/jfr.v5n5p56. 

Keller D, Van Dinter R, Cash H, Farmer S, Venema K. Bacillus coagulans GBI-30, 6086 increases plant protein digestion in a dynamic, computer-controlled in vitro model of the small intestine (TIM-1). Benef Microbes. 2017 May 30;8(3):491-496. doi: 10.3920/BM2016.0196.

Khochamit N, Siripornadulsil S, Sukon P, Siripornadulsil W. Antibacterial activity and genotypic–phenotypic characteristics of bacteriocin-producing Bacillus subtilis KKU213: potential as a probiotic strain. Microbiol Res. 2015 Jan;170:36-50. doi: 10.1016/j.micres.2014.09.004. 

Ahmad K, Fatemeh F, Mehri N, Maryam S. Probiotics for the treatment of pediatric Helicobacter pylori infection: a randomized double blind clinical trial. Iran J Pediatr. 2013 Feb;23(1):79-84. 

Kotb E. Purification and partial characterization of serine fibrinolytic enzyme from Bacillus megaterium KSK-07 isolated from kishk, a traditional Egyptian fermented food. Appl Biochem Microbiol. 2015;51(1):34-43. doi: 10.1134/S000368381501007X.

Kniehl E, Becker A, Forster DH. Pseudo-outbreak of toxigenic Bacillus cereus isolated from stools of three patients with diarrhoea after oral administration of a probiotic medication. J Hosp Infect. 2003 Sep;55(1):33-8. doi: 10.1016/S0195-6701(03)00133-6. 

Kodali VP, Sen R. Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium. Biotechnol J. 2008 Feb;3(2):245-51. doi: 10.1002/biot.200700208.

Kolstø AB, Tourasse NJ, Økstad OA. What sets Bacillus anthracis apart from other Bacillus species. Annu Rev Microbiol. 2009;63:451-76. doi: 10.1146/annurev.micro.091208.073255.

Krawczyk AO, de Jong A, Holsappel S, et al. Genome sequences of 12 spore-forming Bacillus species, comprising Bacillus coagulans, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus sporothermodurans, and Bacillus vallismortis, isolated from foods. Genome Announc. 2016 May 12;4(3). pii: e00103-16. doi: 10.1128/genomeA.00103-16. 

Lee JH, Nam SH, Seo WT, et al. The production of surfactin during the fermentation of cheonggukjang by potential probiotic Bacillus subtilis CSY191 and the resultant growth suppression of MCF-7 human breast cancer cells. Food Chem. 2012;131(4):1347-1354. doi: 10.1016/j.foodchem.2011.09.133.

Lefevre M, Racedo SM, Ripert G, et al. Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immun Ageing. 2015 Dec 3;12:24. doi: 10.1186/s12979-015-0051-y.

London LE, Kumar AH, Wall R, et al. (2014). Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice. J Nutr. 2014 Dec;144(12):1956-62. doi: 10.3945/jn.114.191627.

Haldar L, Gandhi DN. Effect of oral administration of Bacillus coagulans B37 and Bacillus pumilus B9 strains on fecal coliforms, Lactobacillus and Bacillus spp. in rat animal model. Vet World. 2016 Jul;9(7):766-72. doi: 10.14202/vetworld.2016.766-772.

Lopetuso LR, Scaldaferri F, Franceschi F, Gasbarrini A. Bacillus clausii and gut homeostasis: state of the art and future perspectives. Expert Rev Gastroenterol Hepatol. 2016 Aug;10(8):943-8. doi: 10.1080/17474124.2016.1200465.

Majeed M, Prakash L. Lactospore®: The Effective Probiotic. Piscataway, NJ: NutriScience Publishers Inc; 1998.

Mallappa RH, Rokana N, Duary RK, Panwar H, Batish VK, Grover S. Management of metabolic syndrome through probiotic and prebiotic interventions. Indian J Endocrinol Metab. 2012 Jan;16(1):20-7. doi: 10.4103/2230-8210.91178.

Maneerat S, Lehtinen MJ, Childs CE, et al. Consumption of Bifidobacterium lactis Bi-07 by healthy elderly adults enhances phagocytic activity of monocytes and granulocytes. J Nutr Sci. 2014 Jan 2;2:e44. doi: 10.1017/jns.2013.31. 

Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med. 2010 Jan 12;10:1. doi: 10.1186/1472-6882-10-1.

Manhar AK, Bashir Y, Saikia D, et al. Cellulolytic potential of probiotic Bacillus Subtilis AMS6 isolated from traditional fermented soybean (Churpi): An in-vitro study with regards to application as an animal feed additive. Microbiol Res. 2016 May-Jun;186-187:62-70. doi: 10.1016/j.micres.2016.03.004.

Mohammed Y, Lee B, Kang Z, Du G. Development of a two-step cultivation strategy for the production of vitamin B12 by Bacillus megaterium. Microb Cell Fact. 2014 Jul 15;13:102. doi: 10.1186/s12934-014-0102-7. 

Mullany P, Barbosa TM, Scott K, Roberts AP. Mechanisms of gene transfer and the spread of antibiotic resistance in spore forming organisms in the GI tract. In: Ricca E, Henriques AO, Cutting SM, editors. Bacterial Spore Formers: Probiotics and Emerging Applications. Norfolk: Horizon Bioscience; 2004. 113-129 pp.

Muscettola M, Grasso G, Blach-Olszewska Z, et al. Effects of Bacillus subtilis spores on interferon production. Pharmacol Res. 1992 Sep;26 Suppl 2:176-7. doi: 10.1016/1043-6618(92)90652-R. 

Muscettola M, Grasso G, Migliaccio P, Gallo VC. Plasma interferon-like activity in rabbits after oral administration of Bacillus subtilis spores. J Chemother. 1991;3:130-132.

Nagal S, Okimura K, Kaizawa N, Ohki K, Kanatomo S. Study on surfactin, a cyclic depsipeptide II synthesis of surfactin B2 produced by Bacillus natto KMD 2311. Chem Pharm Bull (Tokyo). 1996 Jan;44(1):5-10. 

Nyangale EP, Farmer S, Cash HA, Keller D, Chernoff D, Gibson GR. Bacillus coagulans GBI-30 6086 modulates Faecalibacterium prausnitziiin older men and women. J Nutr. 2015 Jul;145(7):1446-52. doi: 10.3945/jn.114.199802.

Nyangale EP, Farmer S, Keller D, Chernoff D, Gibson GR. Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086. Anaerobe. 2014 Dec;30:75-81. doi: 10.1016/j.anaerobe.2014.09.002.

Ouattara HG, Reverchon S, Niamke SL, Nasser W. Regulation of the synthesis of pulp degrading enzymes in Bacillus isolated from cocoa fermentation. Food Microbiol. 2017 May;63:255-262. doi: 10.1016/j.fm.2016.12.004.

Panwar H, Calderwood D, Grant IR, Grover S, Green BD. Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha-and beta-glucosidases suggesting anti-diabetic potential. Eur J Nutr. 2014 Oct;53(7):1465-74. doi: 10.1007/s00394-013-0649-9.

Panwar H, Calderwood D, Grant IR, Grover S, Green BD. Lactobacilli possess inhibitory activity against dipeptidyl peptidase-4 (DPP-4). Ann. Microbiol. 2016;66(I1):505-509. doi: 10.1007/s13213-015-1129-7. 

Pinchuk IV, Bressollier P, Verneuil B, et al. (2001). In vitro Anti-Helicobacter pylori Activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother. 2001 Nov;45(11):3156-61. doi: 10.1128/AAC.45.11.3156-3161.2001. 

Prokesova L, Novakova M, Julak J, Mara M. Effect of Bacillus firmus and other sporulating aerobic microorganisms on in vitro stimulation of human lymphocytes. A comparative study. Folia Microbiol (Praha). 1994;39(6):501-4. doi: 10.1007/BF02814071.

Ramarao N, Lereclus D. Adhesion and cytotoxicity of Bacillus cereus and Bacillus thuringiensis to epithelial cells are FlhA and PlcR dependent, respectively. Microbes Infect. 2006 May;8(6):1483-91. doi: 10.1016/j.micinf.2006.01.005. 

Ranji P, Akbarzadeh A, Rahmati-Yamchi M. Associations of probiotics with vitamin D and leptin receptors and their effects on colon cancer. Asian Pac J Cancer Prev. 2015;16(9):3621-7. doi: 10.7314/APJCP.2015. 

Rao KP, Chennappa G, Suraj U, Nagaraja H, Raj AP, Sreenivasa MY. Probiotic potential of Lactobacillus strains isolated from sorghum-based traditional fermented food. Probiotics Antimicrob Proteins. 2015 Jun;7(2):146-56. doi: 10.1007/s12602-015-9186-6.

Redman MG, Ward EJ, Phillips RS. The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol. 2014 Oct;25(10):1919-29. doi: 10.1093/annonc/mdu106. 

Rey MW, Ramaiya P, Nelson BA, et al. Complete genome sequence of the industrial bacterium Bacillus licheniformis and comparisons with closely related Bacillus species. Genome Biol. 2004;5(10):R77. doi: 10.1186/gb-2004-5-10-r77. 

Riazi S, Wirawan RE, Badmaev V, Chikindas ML. Characterization of lactosporin, a novel antimicrobial protein produced by Bacillus coagulans ATCC 7050. J Appl Microbiol. 2009 Apr;106(4):1370-7. doi: 10.1111/j.1365-2672.2008.04105.x.

Ripert G, Racedo SM, Elie AM, Jacquot C, Bressollier P, Urdaci MC. Secreted compounds of the probiotic Bacillus clausii strain O/C inhibit the cytotoxic effects induced by Clostridium difficile and Bacillus cereus toxins. Antimicrob Agents Chemother. 2016 May 23;60(6):3445-54. doi: 10.1128/AAC.02815-15. 

Rowan NJ, Deans K, Anderson JG, Gemmell CG, Hunter IS, Chaithong T. Putative virulence factor expression by clinical and food isolates of Bacillus spp. after growth in reconstituted infant milk formulae. Appl Environ Microbiol. 2001 Sep;67(9):3873-81. doi: 10.1128/AEM.67.9.3873-3881.2001. 

Sanchez B, Arias S, Chaignepain S, et al. Identification of surface proteins involved in the adhesion of a probiotic Bacillus cereus strain to mucin and fibronectin. Microbiology. 2009 May;155(Pt 5):1708-16. doi: 10.1099/mic.0.025288-0.

Scientific Committee on Animal Nutrition. Opinion of of the Scientific Steering Committee on Antimicrobial Resistance, 2009. Available from: https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_ssc_out50_en.pdf .

Scientific Committee on Animal Nutrition. Opinion of the Scientific Committee on Animal Nutrition (SCAN) on the use of Bacillus licheniformis NCTC 13123 in Feeding Stuffs for Pigs (product AlCare), 2002. Available from: https://ec.europa.eu/food/sites/food/files/safety/docs/animal-feed_additives_rules_scan-old_report_out79.pdf

Scientific Committee on Animal Nutrition. Opinion of the Scientific Committee on Animal Nutrition, on the Criteria for Assessing the Safety of Microorganisms Resistant to Antibiotics of Human Clinical and Veterinary Importance. EFSA J. 2005 Jun;223:1-12. doi: 10.2903/j.efsa.2005.223.

Scott KP, Antoine JM, Midtvedt T, van Hemert S. Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis. 2015 Feb 2;26:25877. doi: 10.3402/mehd.v26.25877. 

Shida K, Nomoto K. Probiotics as efficient immuno potentiators: translational role in cancer prevention. Indian J Med Res. 2013 Nov;138(5):808-14.

Shimizu, Ogura H, Asahara T, et al. (2013). Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective. Dig Dis Sci. 2013 Jan;58(1):23-32. doi: 10.1007/s10620-012-2334-x.

Shobharani P, Padmaja RJ, Halami PM. Diversity in the antibacterial potential of probiotic cultures Bacillus licheniformis MCC2514 and Bacillus licheniformis MCC2512. Res Microbiol. 2015 Jul-Aug;166(6):546-54. doi: 10.1016/j.resmic.2015.06.003.

Sorokulova IB, Pinchuk IV, Denayrolles M, et al. The safety of two Bacillus probiotic strains for human use. Dig. Dig Dis Sci. 2008 Apr;53(4):954-63. doi: 10.1007/s10620-007-9959-1. 

Smirnov VV, Reznik SR, V'iunitskaia VA, Sorokulova IB, Litvin VP. The effect of the complex probiotic Sporolact on the intestinal microbiocenosis of warm-blooded animals. Mikrobiol Z. 1995 Jul-Aug;57(4):42-9. (in Russian).

Sudha RM, Bhonagiri S. Efficacy of Bacillus coagulans strain Unique IS-2 in the treatment of patients with acute diarrhea. Int J Probiotics Prebiotics 2012;7(1):33-37.

Takano H. The regulatory mechanism underlying light-inducible production of carotenoids in non phototrophic bacteria. Biosci Biotechnol Biochem. 2016 Jul;80(7):1264-73. doi: 10.1080/09168451.2016.1156478. 

Tam NK, Uyen NQ, Hong HA, et al. The intestinal life cycle of Bacillus subtilis and close relatives. J Bacteriol. 2006 Apr;188(7):2692-700. doi: 10.1128/JB.188.7.2692-2700.2006. 

Tamang JP, Watanabe K, Holzapfel WH. Review: diversity of microorganisms in global fermented foods and beverages. Front Microbiol. 2016 Mar 24;7:377. doi: 10.3389/fmicb.2016.00377. 

Tanaka K, Takanaka S, Yoshida KI. A second-generation Bacillus cell factory for rare inositol production. Bioengineered. 2014 Sep-Oct;5(5):331-4. doi: 10.4161/bioe.29897. 

Terlabie NN, Sakyi-Dawson E, Amoa-Awua WK. The comparative ability of four isolates of Bacillus subtilis to ferment soybeans into dawadawa. Int J Food Microbiol. 2006 Feb 1;106(2):145-52. doi: 10.1016/j.ijfoodmicro.2005.05.021. 

Tewari VV, Dubey SK, Gupta G. Bacillus clausii for prevention of late-onset sepsis in preterm infants: a randomized controlled trial. J Trop Pediatr. 2015 Oct;61(5):377-85. doi: 10.1093/tropej/fmv050.

Thakur N, Rokana N, Panwar H. Probiotics: selection criteria, safety and role in health and disease. J Innov Biol. 2016;3(1):259-270.

Trocino A, Xiccato G, Carraro L, Jimenez G. Effect of diet supplementation with Toyocerin® (Bacillus cereus var. toyoi) on performance and health of growing rabbits. World Rabbit Sci. 2010;13(1):17-28. doi: 10.4995/wrs.2005.532.

Urgesi R, Casale C, Pistelli R, Rapaccini GL, de Vitis I. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2014;18(9):1344-53.

Voichishina LG, Chaplinskii V, Vjunitskaia VA. The use of sporulating bacteria in treating patients with dysbacteriosis. Vrach Delo. 1991;(12):73-75.

Mollendorff JW, Vaz-Velho M, Todorov SD. Boza, a traditional cereal-based fermented beverage: a rich source of probiotics and bacteriocin-producing lactic acid bacteria. In: Kristbergsson K., Ötles S, editors. Functional Properties of Traditional Foods.  Boston, MA: Springer; 2016. 157-188 pp.

Wang J, Tang H, Zhang C, et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J. 2015 Jan;9(1):1-15. doi: 10.1038/ismej.2014.99. 

Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. Can Vet J. 2011 Jan;52(1):43-6.

Wu T, Zhang Y, Lv Y, et al. Beneficial Impact and Molecular Mechanism of Bacillus coagulans on Piglets' Intestine. Int J Mol Sci. 2018 Jul 18;19(7). pii: E2084. doi: 10.3390/ijms19072084.

Xu D, Cote JC. Phylogenetic relationships between Bacillus species and related genera inferred from comparison of 3′ end 16S rDNA and 5′ end 16S–23S ITS nucleotide sequences. Int J Syst Evol Microbiol. 2003 May;53(Pt 3):695-704. doi: 10.1099/ijs.0.02346-0. 

Yang HJ, Kwon DY, Kim HJ, et al. Fermenting soybeans with Bacillus licheniformis potentiates their capacity to improve cognitive function and glucose homeostaisis in diabetic rats with experimental Alzheimer’s type dementia. Eur J Nutr. 2015 Feb;54(1):77-88. doi: 10.1007/s00394-014-0687-y. 

Yang OO, Kelesidis T, Cordova R, Khanlou H. Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial. AIDS Res Hum Retroviruses. 2014 Oct;30(10):988-95. doi: 10.1089/AID.2014.0181. 

Zhang HL, Li WS, Xu DN, et al. Mucosa-reparing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice. Exp Ther Med. 2016 Oct;12(4):2554-2562. doi: 10.3892/etm.2016.3686. 

Zhao C, Lv X, Fu J, He C, Hua H, Yan Z. In vitro inhibitory activity of probiotic products against oral Candida species. J Appl Microbiol. 2016 Jul;121(1):254-62. doi: 10.1111/jam.13138.

Zheng LP, Zou T, Ma YJ, Wang JW, Zhang YQ. Antioxidant and DNA damage arotecting Activity of exopolysaccharides from the endophytic bacterium Bacillus Cereus SZ1. Molecules. 2016 Feb 4;21(2). pii: E174. doi: 10.3390/molecules21020174.

Zouari R, Abdallah-Kolsi RB, Hamden K, et al. Assessment of the antidiabetic and antilipidemic properties of Bacillus subtilis SPB1 biosurfactant in alloxan-induced diabetic rats. Biopolymers. 2015 Nov;104(6):764-74. doi: 10.1002/bip.22705. 

Mechnikov II. Sketches of optimism. Novosibirsk: Nauka; 1988. 244 p.

Harchenko NV. The study of the effectiveness of Laktovit Forte in chronic diseases of the gastrointestinal tract with intestinal dysbiosis syndrome. Modern Gastroenterology. 2007;(35):53-56. (In Ukrainian).

Kvashnina LV, Rodionov VP, Matviienko IM. Possibilities of Correction for Iron Deficiency and Intestinal Microbiocenosis Disorders in Children. Zdorov`e rebenka. 2016;(74):14-20. doi: 10.22141/2224-0551.6.74.2016.82125. (In Russian).

Kvashnina LV, Rodionov VP. Correction of intestinal dysbiosis in the process of rehabilitation of children of primary school age after infectious gastroenterocolitis. Zdorov`e rebenka. 2012;(42):134-138. (In Russian).

Podolsky VlV, Podolsky VV. Treatment of urogenital microbiocenosis changes in women with disorders of autonomic homeostasis and reproductive health changes. Health of woman. 2015;(106):125-128.

Available from: https://www.ncbi.nlm.nih.gov/genome.

Orrù L, Salvetti E, Cattivelli L, et al. Draft Genome Sequence of Bacillus coagulans GBI-30, 6086, a Widely Used Spore-Forming Probiotic Strain. Genome Announc. 2014 Nov 6;2(6). pii: e01080-14. doi: 10.1128/genomeA.01080-14.

FDA. GRAS Notice Inventory. Available from: https://www.fda.gov/food/ingredientspackaginglabeling/gras/noticeinventory/default.htm. Accessed: September 26, 2018.

Available from: www.who.int.

Downloads

Published

2021-09-07

How to Cite

Vysochina, I. (2021). B.coagulans in the treatment of gastrointestinal diseases of inflammatory and functional nature: effectiveness from the standpoint of evidence-based medicine. GASTROENTEROLOGY, 52(4), 227–242. https://doi.org/10.22141/2308-2097.52.4.2018.154143

Issue

Vol. 52 No. 4 (2018)

Section

Reviews and Lections

License

Copyright (c) 2018 I.L. Vysochina

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.